Quick Takeaways
- Wei-Wu He filed SCHEDULE 13D/A for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI).
- Disclosed ownership: 45%.
- Date of event: 09 Feb 2026.
Wei-Wu He - 09 Feb 2026 SCHEDULE 13D/A Report for CASI Pharmaceuticals, Inc. Ordinary Shares (CASI)
- Filing Manager
- Wei-Wu He
- Reporting Manager
- WEI-WU HE, Ph.D.
- Symbol
- CASI
- Shares outstanding
- 30,761,090 shares
- Disclosed Ownership
- 13,965,535 shares
- Ownership
- 45%
- Form type
- SCHEDULE 13D/A
- Filing time
- 10 Feb 2026, 06:01:54 UTC
- Date of event
- 09 Feb 2026
- Previous filing
- 29 Jan 2026
- Next filing
- 23 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Wei-Wu He disclosed 45% ownership in CASI Pharmaceuticals, Inc. Ordinary Shares (CASI) on 09 Feb 2026."
What Changed
- Previous schedule filing date: 29 Jan 2026.
- Current filing was accepted on 10 Feb 2026, 06:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (7)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| WEI-WU HE, Ph.D. | 45% | 13,965,535 | 2,130,550 | 11,834,985 | /s/ Wei-Wu He, Ph.D. | Wei-Wu He, Ph.D. | 0001542073 |
| HUIYING MEMORIAL FOUNDATION | 3.1% | 637,644 | 0 | 637,644 | /s/ Wei-Wu He, Ph.D. | Wei-Wu He, Ph.D./President | |
| EMERGING TECHNOLOGY PARTNERS, LLC | 5.3% | 1,097,341 | 0 | 1,097,341 | /s/ Wei-Wu He, Ph.D. | Wei-Wu He, Ph.D./ Managing Member | |
| ETP Global Fund L.P. | 3.7% | 753,234 | 0 | 753,234 | EMERGING TECHNOLOGY PARTNERS, LLC | General Partner | |
| ETP BIOHEALTH III FUND, L.P. | 1.5% | 300,000 | 0 | 300,000 | EMERGING TECHNOLOGY PARTNERS, LLC | General Partner | |
| HE Family GRAT | 0.5% | 100,000 | 0 | 100,000 | /s/ Wei-Wu He, Ph.D. | Wei-Wu He, Ph.D./Trustee | |
| ETP Global Fund III L.P. | 33% | 10,000,000 | 0 | 10,000,000 | EMERGING TECHNOLOGY PARTNERS, LLC | General Partner |